41
In fiscal year 2022 , there was renewed focus on clinical trials and research . Key studies related to valve disorders included :
ACURATE – New generation transfemoral aortic valve system with other commercially available valves . Principal investigator : Robert Stoler , MD , FACC , FSCAI .
APOLLO – Transcatheter mitral valve replacement with Medtronic Intrepid™ system in patients with severe mitral regurgitation . Principal investigator : Ravi Vallabhan , MD , FACC , FSCAI .
SUMMIT – Evaluating safety and effectiveness of Tendyn™ Mitral Valve System for mitral regurgitation . Principal investigator : Robert F . Hebeler , Jr ., MD , FACS .
Key publications
Specialists on the hospital medical staff involved with the Center for Valve Disorders authored many journal articles in fiscal year 2022 .
• Arunthamakun J , Vallabhan R , Ayad R , Roberts CC . Shotgun recoil causing severe acute aortic regurgitation years after replacement of the aortic valve and ascending aorta . Proceedings Baylor University Medical Center . 2021 Oct 25:35 ( 1 ): 96-97 .
• Hebeler KR , Ogola G , Filardo G , Mack M , Stoler R , Mixon T , Szerlip M , Edgerton J , Hebeler RF Jr . Comparison of outcomes after transcatheter aortic valve implantation following home versus nonhome discharge . Proceedings Baylor University Medical Center . 2022 May 16 ; 35 ( 4 ): 428-433 .
• Nazif TM , Moses J , Sharma R , Dhoble A , Rovin J , Brown D , Horwitz P , Makkar R , Stoler R , et al . REFLECT II Trial Investigators - Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement : REFLECT II . Journal American College of Cardiology - Cardiology Interventions . 2021 Mar 8 ; 14 ( 5 ): 515-527 .
• Sudhakaran S , Tandon A , Rafael AE , Choi JW . Severe mitral paravalvular leak treated with percutaneous paravalvular leak closure with underlying severe mitral annular calcium . American Journal of Cardiology . 2021 Aug 1 ; 152:165-167 .
For more information about the Center for Valve Disorders : 214.820.3604 , BSWHealth . com / DallasHeartValveCenter
SMART - Small Annuli Randomized to Evolut or Sapien Trial . In July 2021 , the Dallas site was the first in the state of Texas to enroll patients in SMART trial Principal investigator : Robert Stoler , MD , FACC , FSCAI .
PROTECTED TAVR – Prospective , post-market , multi-center randomized controlled trial evaluating use of the Sentinel Cerebral Protection System in aortic stenosis patients who have been treated with a commercially available TAVR device . Principal investigator : Robert Stoler , MD , FACC , FSCAI .
For an up-to-date listing of all clinical trials and research for Baylor Scott & White Health , visit BRITrials . BSWSites . com .
Baylor Scott & White Heart and Vascular Hospital - Dallas | Center for Valve Disorders